Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?
Denmark's Novo Nordisk's obesity drug ‘Wegovy Pill (ingredient name Semaglutide)’ has recently been launched in the U. S.
Search results for "U.S. clinical trial"
Abl Bio Confirms Positive Effects of Cancer Drug 'ABL111' in Phase 1b Clinical Trial
Abl Bio announced on the 7th that it has confirmed positive anti-cancer efficacy in the dose expansion cohort of the Phase 1b clinical trial for its...
Thoughts on Coffee, Is There Something to Change?…Recent Studies Show Three Findings
It seems that three thoughts about coffee need to be changed in the future. The Australian online media ‘New Atlas’...
Samsung Bioepis to Directly Sell Ophthalmic Drug Baivubiz in Europe
Samsung Bioepis announced on the 4th that it has recovered the European commercialization rights for the ophthalmic...
Personalized Cancer Vaccine That 'Remembers Cancer' Opens New Pathways
A domestic research team has developed artificial intelligence -based personalized cancer vaccine design technology...